Targeting acidosis to improve immunotherapy in a pancreatic ductal adenocarcinoma model

被引：0
|
作者：
Perassi, B. Victorasso Jardim [1 ]
Abrahams, D. [2 ]
Irrera, P. [1 ]
Whelan, C. [3 ]
Beatty, M. [4 ]
Byrne, S. [4 ]
Longo, D. [5 ]
Gaspar, K. [6 ]
Pilon-Thomas, S. [4 ]
Hashim, A. Ibrahim [1 ]
Bohler, C. [6 ]
Gillies, R. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Physiol, Tampa, FL USA
[2] Univ S Florida, Comparat Med, Tampa, FL 33620 USA
[3] Univ Illinois, Biol Sci, Chicago, IL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Immunol, Tampa, FL USA
[5] CNR, Inst Biostruct & Bioimages, Turin, Italy
[6] Helix BioPharma Corp, Toronto, ON, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
250
引用
收藏
页码：S90 / S91
页数：2
相关论文
共 50 条
  • [41] Resolving and Targeting the Mechanobiome of Pancreatic Ductal Adenocarcinoma.
    Surcel, A.
    Zhu, Q.
    Schiffhauer, E.
    Anders, R. A.
    Robinson, D. N.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [42] Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy
    Zhang, Yi-Fan
    Jiang, Shu-Heng
    Hu, Li-Peng
    Huang, Pei-Qi
    Wang, Xu
    Li, Jun
    Zhang, Xue-Li
    Nie, Hui-Zhen
    Zhang, Zhi-Gang
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
  • [43] Targeting macrophages to degrade fibrosis in pancreatic ductal adenocarcinoma
    Long, Kristen B.
    Luque, Santiago L.
    Beatty, Gregory L.
    CANCER RESEARCH, 2015, 75
  • [44] A novel bifunctional antibody format for immunotherapy of pancreatic ductal adenocarcinoma: combining a targeting with a checkpoint blocking domain
    Reischer, A.
    Rothe, M.
    Kozik, J. -H.
    Kruger, S.
    Westphalen, C. B.
    Schele, A.
    Ponce, L. P.
    Fenn, N.
    Hopfner, K. -P.
    Ormanns, S.
    von Bergwelt, M.
    Boeck, S.
    Heinemann, V.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 33 - 33
  • [45] Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
    Panagiotis Sarantis
    Evangelos Koustas
    Adriana Papadimitropoulou
    Athanasios G Papavassiliou
    Michalis V Karamouzis
    World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 173 - 181
  • [46] Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
    Chen, Hao
    Yang, Gang
    Xiao, Jianchun
    Zheng, Lianfang
    You, Lei
    Zhang, Taiping
    CANCER LETTERS, 2020, 490 : 12 - 19
  • [47] Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
    Sarantis, Panagiotis
    Koustas, Evangelos
    Papadimitropoulou, Adriana
    Papavassiliou, Athanasios G.
    Karamouzis, Michalis, V
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (02) : 173 - 181
  • [48] Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinoma
    Beatty, Gregory L.
    ONCOIMMUNOLOGY, 2013, 2 (12)
  • [49] The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
    Hilmi, Marc
    Delaye, Matthieu
    Muzzolini, Milena
    Nicolle, Remy
    Cros, Jerome
    Hammel, Pascal
    Cardot-Ruffino, Victoire
    Neuzillet, Cindy
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1129 - 1142
  • [50] Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
    Pham, Thao N. D.
    Shields, Mario A.
    Spaulding, Christina
    Principe, Daniel R.
    Li, Bo
    Underwood, Patrick W.
    Trevino, Jose G.
    Bentrem, David J.
    Munshi, Hidayatullah G.
    CANCERS, 2021, 13 (03) : 1 - 22
12345